Literature DB >> 15361883

Regulation of B-cell survival by BAFF-dependent PKCdelta-mediated nuclear signalling.

Ingrid Mecklenbräuker1, Susan L Kalled, Michael Leitges, Fabienne Mackay, Alexander Tarakhovsky.   

Abstract

Approximately 65% of B cells generated in human bone marrow are potentially harmful autoreactive B cells. Most of these cells are clonally deleted in the bone marrow, while those autoreactive B cells that escape to the periphery are anergized or perish before becoming mature B cells. Escape of self-reactive B cells from tolerance permits production of pathogenic auto-antibodies; recent studies suggest that extended B lymphocyte survival is a cause of autoimmune disease in mice and humans. Here we report a mechanism for the regulation of peripheral B-cell survival by serine/threonine protein kinase Cdelta (PKCdelta): spontaneous death of resting B cells is regulated by nuclear localization of PKCdelta that contributes to phosphorylation of histone H2B at serine 14 (S14-H2B). We show that treatment of B cells with the potent B-cell survival factor BAFF ('B-cell-activating factor belonging to the TNF family') prevents nuclear accumulation of PKCdelta. Our data suggest the existence of a previously unknown BAFF-induced and PKCdelta-mediated nuclear signalling pathway which regulates B-cell survival.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15361883     DOI: 10.1038/nature02955

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  48 in total

1.  Transcription factor Ebf1 regulates differentiation stage-specific signaling, proliferation, and survival of B cells.

Authors:  Ildiko Györy; Sören Boller; Robert Nechanitzky; Elizabeth Mandel; Sebastian Pott; Edison Liu; Rudolf Grosschedl
Journal:  Genes Dev       Date:  2012-03-19       Impact factor: 11.361

2.  The dependence receptor Ret induces apoptosis in somatotrophs through a Pit-1/p53 pathway, preventing tumor growth.

Authors:  Carmen Cañibano; Noela L Rodriguez; Carmen Saez; Sulay Tovar; Montse Garcia-Lavandeira; Maria Grazia Borrello; Anxo Vidal; Frank Costantini; Miguel Japon; Carlos Dieguez; Clara V Alvarez
Journal:  EMBO J       Date:  2007-03-22       Impact factor: 11.598

3.  NIK overexpression amplifies, whereas ablation of its TRAF3-binding domain replaces BAFF:BAFF-R-mediated survival signals in B cells.

Authors:  Yoshiteru Sasaki; Dinis P Calado; Emmanuel Derudder; Baochun Zhang; Yuri Shimizu; Fabienne Mackay; Shin-ichi Nishikawa; Klaus Rajewsky; Marc Schmidt-Supprian
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-28       Impact factor: 11.205

Review 4.  Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury.

Authors:  D P Ankeny; P G Popovich
Journal:  Neuroscience       Date:  2008-07-04       Impact factor: 3.590

Review 5.  Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions.

Authors:  Joanne M Hildebrand; Zuoan Yi; Claire M Buchta; Jayakumar Poovassery; Laura L Stunz; Gail A Bishop
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

Review 6.  Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease.

Authors:  Robert C Rickert; Julia Jellusova; Ana V Miletic
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

Review 7.  Roles of TRAF molecules in B lymphocyte function.

Authors:  Ping Xie; Zachary J Kraus; Laura L Stunz; Gail A Bishop
Journal:  Cytokine Growth Factor Rev       Date:  2008-05-21       Impact factor: 7.638

Review 8.  Translational Mini-Review Series on B Cell-Directed Therapies: B cell-directed therapy for autoimmune diseases.

Authors:  C Hu; F S Wong; L Wen
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

Review 9.  BAFF and the plasticity of peripheral B cell tolerance.

Authors:  Jason E Stadanlick; Michael P Cancro
Journal:  Curr Opin Immunol       Date:  2008-05-02       Impact factor: 7.486

10.  Role of the translocation partner in protection against AID-dependent chromosomal translocations.

Authors:  Mila Jankovic; Davide F Robbiani; Yair Dorsett; Thomas Eisenreich; Yang Xu; Alexander Tarakhovsky; Andre Nussenzweig; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.